Generic Videx EC ( Didanosine )

Videx EC

Videx EC (didanosine, also known as ddI) is a delayed‑release enteric‑coated capsule formulation of didanosine, a nucleoside reverse transcriptase inhibitor (NRTI) of the adenosine analogue class. It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection in adults and children who can swallow capsules. Didanosine is phosphorylated intracellularly to its active metabolite, dideoxyadenosine triphosphate, which inhibits HIV‑1 reverse transcriptase by competing with natural adenosine triphosphate and by incorporating into viral DNA, causing chain termination. Due to significant toxicities, including pancreatitis, peripheral neuropathy, and lactic acidosis, didanosine is no longer a preferred first‑line agent in Canada and is reserved for patients with limited treatment options. It must always be used as part of a multi‑drug antiretroviral regimen.

Usual adult dose: For adults weighing 60 kg or more, the recommended dose is 400 mg once daily. For adults weighing less than 60 kg, the dose is 250 mg once daily. Videx EC capsules must be swallowed whole with at least 100 mL of water on an empty stomach, at least 2 hours before or 2 hours after a meal; food reduces the absorption of didanosine significantly. The capsules must not be opened, crushed, or chewed, as the enteric coating protects the drug from degradation by gastric acid. Dose reduction is required in renal impairment. If a dose is missed, the patient should take it as soon as remembered, but two doses must not be taken at the same time. Didanosine is never used as monotherapy.

Dosage form: Enteric‑coated (delayed‑release) capsules: 400 mg (white, opaque, imprinted with “BMS 400 mg” and “6672”). Also available as 125 mg, 200 mg, and 250 mg strengths. The 400 mg capsule is the standard daily dose for patients weighing 60 kg or more.

Onset of action: Didanosine is rapidly absorbed after oral administration of the enteric‑coated capsule, with peak plasma concentrations reached approximately 2 hours post‑dose. Antiretroviral activity, measured by a decline in HIV‑1 RNA, is evident within the first weeks of therapy when combined with other active drugs; maximal viral suppression typically requires 12 to 24 weeks of consistent adherence.

Duration of action: The intracellular half‑life of the active triphosphate is approximately 25 hours, permitting once‑daily dosing. The elimination half‑life of didanosine in plasma is about 1.5 hours, but the pharmacodynamic effect persists much longer due to the sustained intracellular concentration of the active metabolite.

Alcohol recommendation: Alcohol must be avoided during treatment with didanosine. Both chronic and binge alcohol consumption increase the risk of pancreatitis, a potentially fatal adverse effect already associated with didanosine. In addition, alcohol may exacerbate the hepatic steatosis and lactic acidosis that are known to occur with NRTI therapy. Patients should be counselled on complete abstinence from alcohol while on this medication.

Most common side effects: Diarrhea, nausea, vomiting, abdominal pain, headache, and rash. The most serious toxicities are pancreatitis (sometimes fatal), lactic acidosis with hepatic steatosis, and dose‑limiting peripheral neuropathy. Patients must be monitored for signs of pancreatitis (elevated amylase/lipase, severe abdominal pain, nausea) and for symptoms of neuropathy (numbness, tingling, or burning pain in the hands and feet). Liver function tests, serum electrolytes, and acid‑base balance should be monitored regularly. In patients co‑infected with hepatitis B or C, or in those with elevated baseline liver enzymes, the risk of hepatic decompensation is increased. Retinal changes and optic neuritis have been reported in children; periodic ophthalmologic evaluation is recommended. Didanosine should not be co‑administered with allopurinol, ribavirin, or stavudine due to serious drug interactions. Immune reconstitution inflammatory syndrome (IRIS) may occur following the initiation of combination antiretroviral therapy. Didanosine is a pregnancy category B drug, but lactic acidosis has been reported in pregnant women receiving didanosine and stavudine together; this combination must be avoided. Videx EC is available only by prescription and must be initiated and supervised by a healthcare professional experienced in HIV management.

Would you like to try Videx EC (Didanosine) without a prescription?

Select doses
Select Package
Videx EC
400 mg
x
30 pills
$503.99
$ 419.99
$ 14.00 per pill
save:  $0.00
Videx EC
400 mg
x
60 pills
$791.99
$ 659.99
$ 11.00 per pill
save:  $180.00
Videx EC
400 mg
x
90 pills
$1151.99
$ 959.99
$ 10.67 per pill
save:  $299.70

Buy Generic Videx EC (Didanosine) without prescription in Canada

At our pharmacy, you can buy Videx EC without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.

What is Videx EC?

Videx EC is an antiretroviral medication used as part of combination therapy to treat HIV-1 infection. The active ingredient is didanosine, a nucleoside reverse transcriptase inhibitor (NRTI). It's one of the older drugs in the HIV arsenal, but it still holds a place for people whose virus has developed resistance to newer options or who need an alternative backbone when others aren't tolerated. The "EC" stands for enteric-coated, a formulation designed to protect the drug from being destroyed by stomach acid and to reduce the gastrointestinal side effects that plagued the original buffered formulation.

Didanosine works by mimicking the natural building blocks of DNA. Once inside an HIV-infected cell, it's converted into its active form, ddATP, and gets incorporated into the growing viral DNA chain by the reverse transcriptase enzyme. Because it lacks a crucial chemical group needed to attach the next building block, the chain stops dead. No full viral DNA, no new virus. The EC capsule allows for once-daily dosing, which is a significant convenience over the old twice-daily powder. The 400 mg capsule is the standard strength for adults weighing 60 kg or more. It's not a cure, but it can keep viral load undetectable and CD4 counts up when taken consistently with other active drugs.

Mechanism and Pharmacology

Didanosine is a synthetic purine nucleoside analogue of deoxyadenosine. Inside the cell, it undergoes a series of phosphorylation steps, first by 5'-nucleotidase and then by adenylate kinase and other enzymes, to become its active metabolite, dideoxyadenosine triphosphate (ddATP). ddATP competes with the natural substrate, deoxyadenosine triphosphate, for incorporation into the HIV DNA chain by reverse transcriptase. Once incorporated, the absence of a 3'-hydroxyl group prevents the formation of a phosphodiester bond with the next nucleotide. Chain elongation stops. This mechanism is the same as other NRTIs, but didanosine's specific activation pathway and resistance profile make it distinct.

The enteric-coated capsule is designed to release the drug in the small intestine rather than the stomach, which minimizes the breakdown by stomach acid and reduces the nausea that made the original formulation so difficult to tolerate. After absorption, peak plasma levels are reached in about 2 hours. Food reduces and delays absorption significantly, so the capsule must be taken on an empty stomach, at least 30 minutes before or 2 hours after a meal. The half-life of the active intracellular metabolite is much longer than the plasma half-life of the drug itself, allowing for once-daily dosing. Didanosine is cleared primarily by the kidneys, with active tubular secretion playing a role. The dose must be reduced in patients with impaired kidney function. Unlike some other NRTIs, didanosine is not heavily metabolized by the liver, but hepatic impairment still warrants caution.

How to Use Videx EC

The dose depends on your body weight. For adults weighing 60 kg or more, the standard dose is one 400 mg capsule taken once daily. For those weighing less than 60 kg, the dose is 250 mg once daily. The capsule must be swallowed whole with water. Do not crush, chew, or open it. The enteric coating is what makes the drug tolerable, and breaking it defeats the purpose.

Timing relative to food is critical. Take the capsule on an empty stomach, at least 30 minutes before a meal or 2 hours after a meal. Food, especially a fatty meal, can drastically reduce the amount of drug absorbed. If you forget a dose and it's within a few hours of your usual time, take it as soon as you remember, still adhering to the empty-stomach rule. If it's almost time for your next dose, skip the missed one. Never double up. Taking too much didanosine sharply raises the risk of pancreatitis and nerve damage.

Your doctor will monitor your weight, kidney function, and liver enzymes regularly. The dose must be adjusted if your kidney function declines. Creatinine clearance is the guide, and a lower dose or longer interval may be prescribed. Do not adjust the dose yourself. Because Videx EC is always used in combination with other antiretrovirals, you need to take all your medications exactly as prescribed. Skipping doses of your entire regimen leads to drug resistance.

Side Effects of Videx EC

The most serious toxicity associated with didanosine is pancreatitis. This can be fatal. The risk is higher in people with advanced HIV, in those who drink alcohol heavily, and in those taking other drugs that can inflame the pancreas, such as pentamidine or certain other NRTIs. Symptoms include severe upper abdominal pain that radiates to the back, nausea, and vomiting. If this happens, stop the drug and seek emergency care immediately.

Peripheral neuropathy is another well-known and potentially treatment-limiting side effect. It causes a tingling, numbness, burning, or shooting pain in the hands and feet. It develops over weeks to months and can be permanent if the drug isn't stopped early. Any new nerve symptoms must be reported immediately. Lactic acidosis and severe hepatomegaly with steatosis, a buildup of fat in the liver, is a rare but life-threatening mitochondrial toxicity shared by several NRTIs. It presents with profound fatigue, nausea, abdominal pain, and shortness of breath. Blood lactate levels rise, and the liver swells. This is a medical emergency.

Other side effects include diarrhea, nausea, headache, and rash. Didanosine can also cause retinal changes and optic neuritis, so regular eye exams are recommended. It can elevate uric acid levels, sometimes triggering gout. The EC formulation causes less diarrhea and bloating than the old buffered tablets, but gastrointestinal upset is still possible, especially at the start of treatment. Taking the capsule on an empty stomach exactly as directed minimizes these effects.

High-Risk Groups (Elderly, Pregnancy)

Pregnancy. Didanosine is pregnancy category B. It has been used during pregnancy when other options were limited, and the Antiretroviral Pregnancy Registry has not shown a clear increase in birth defects. However, the combination of didanosine and stavudine during pregnancy has been associated with an increased risk of lactic acidosis, and this combination is now contraindicated. Modern guidelines favor integrase inhibitors or boosted protease inhibitors with a safer NRTI backbone during pregnancy. If you are pregnant or planning to become pregnant, your HIV specialist will discuss the safest and most effective regimen for you and your baby. Do not stop your medication without guidance, as uncontrolled HIV poses a grave risk to the fetus.

Breastfeeding is not recommended for women with HIV in Canada, regardless of the medication. The virus can be transmitted through breast milk, and formula feeding is the standard recommendation to protect the infant.

Elderly patients often have age-related declines in kidney function, and didanosine is cleared by the kidneys. Doses must be carefully calculated based on creatinine clearance, and lab values should be checked frequently. Older adults may also be more vulnerable to peripheral neuropathy and pancreatitis. Children can take didanosine, but the dosing is weight-based, and the EC capsules are not suitable for very young children; a pediatric powder formulation is available. Patients with pre-existing kidney disease need a reduced dose. Those with a history of pancreatitis, heavy alcohol use, or pre-existing peripheral neuropathy should not take didanosine unless there are no other alternatives and the benefits are judged to outweigh the risks.

Interaction With Activities (Driving, Alcohol)

Didanosine does not directly impair alertness or coordination for most people. However, the peripheral neuropathy it can cause may make driving difficult if you lose sensation in your feet. Alcohol is a major concern. Heavy drinking is a strong risk factor for pancreatitis, and didanosine independently raises that risk. The combination can be deadly. If you take Videx EC, you should avoid alcohol entirely, or at the absolute minimum, keep it to rare, light occasions and never binge drink. Alcohol also damages the liver, adding to the risk of lactic acidosis.

Drug Interactions

The interaction between didanosine and tenofovir is especially dangerous. Tenofovir increases didanosine blood levels by about 40 to 60 percent, which dramatically increases the risk of pancreatitis and peripheral neuropathy. This combination should be avoided. If it must be used, a drastic dose reduction of didanosine and extremely close monitoring are required, but alternatives are almost always preferred.

Allopurinol, a drug for gout, also increases didanosine levels, and the combination should be avoided if possible. Ribavirin, used to treat hepatitis C, can inhibit the phosphorylation of didanosine, leading to increased toxicity and cases of fatal hepatic failure when the two were used together; the combination is contraindicated. Ganciclovir and valganciclovir, used for CMV infections, can increase didanosine levels, and careful monitoring is needed. Methadone can reduce didanosine absorption, though the clinical significance is not fully clear, and monitoring for breakthrough HIV replication is wise. The buffered formulations of didanosine interfere with the absorption of some protease inhibitors and other drugs that need stomach acid, but the EC formulation largely avoids this particular interaction. Nonetheless, always space your antiretrovirals and any antacids or supplements by at least 2 hours.

Alternative Options

Videx EC is an older NRTI, and for most people starting HIV treatment today, it is not the first choice. Newer NRTIs like tenofovir (available as tenofovir disoproxil fumarate, TDF, and tenofovir alafenamide, TAF) and abacavir are preferred because they are better tolerated, can be taken with food, have fewer long-term toxicities, and are co-formulated into single-tablet regimens. Emtricitabine and lamivudine are also widely used. Didanosine is reserved for patients whose virus has resistance to these newer options, or who cannot tolerate them. Integrase inhibitors, such as dolutegravir and bictegravir, are now the cornerstone of most first-line regimens, often combined with TAF/emtricitabine. Protease inhibitors boosted with ritonavir or cobicistat, and non-nucleoside reverse transcriptase inhibitors like doravirine, are alternatives when integrase inhibitors aren't appropriate. Your HIV specialist will select a regimen based on your virus's resistance profile, your kidney function, your bone health, and your lifestyle.

INN, Brand Names, and Classification in Canada

INN (International Nonproprietary Name): Didanosine
Available brand names in Canada: Videx EC, and generic didanosine enteric-coated capsules
ATC code: J05AF02
Forms and strengths: Enteric-coated capsules 125 mg, 200 mg, 250 mg, 400 mg. The 400 mg capsule is for once-daily dosing in adults weighing 60 kg or more.
Manufacturers: Bristol-Myers Squibb Canada (Videx EC), and generic manufacturers including Apotex Inc. and Teva Canada Limited.
Registration status in Canada: Registered
Classification: Prescription (Rx)

Frequently Asked Questions

Why must I take Videx EC on an empty stomach?
Food, especially anything with fat, can cut the amount of drug your body absorbs by half. Taking it exactly as directed, at least 30 minutes before or 2 hours after eating, ensures you get the full dose needed to suppress the virus.

What are the early signs of pancreatitis I should watch for?
A sudden, severe pain in the upper stomach that bores through to your back, along with nausea and vomiting. If this happens, stop the drug immediately and go to the emergency room. Early recognition can save your life.

Can I take this if I have tingling in my feet from another cause?
You must discuss this with your doctor. Didanosine can cause or worsen peripheral neuropathy. If you already have nerve damage from diabetes, chemotherapy, or another NRTI, another drug may be a safer choice.

Is Videx EC still used given all the newer HIV drugs?
Yes, though much less commonly. It remains a valuable option for people with virus that is resistant to newer NRTIs like tenofovir or abacavir. In carefully selected patients, it can still be a life-saving part of a salvage regimen.

Delivery Information Across Canada

We ship Videx EC and generic didanosine to all provinces and territories. Delivery times vary depending on how remote your location is:

  • Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
  • Quebec (Montreal, Quebec City, Laval): 5 to 7 days
  • British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
  • Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
  • Manitoba (Winnipeg, Brandon): 5 to 9 days
  • Saskatchewan (Saskatoon, Regina): 5 to 9 days
  • Nova Scotia (Halifax, Sydney): 5 to 9 days
  • New Brunswick (Moncton, Fredericton): 5 to 9 days
  • Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
  • Prince Edward Island (Charlottetown): 7 to 14 days
  • Yukon, Northwest Territories, Nunavut: 7 to 14 days

All shipments are packed discreetly with no branding or indication of contents on the outside.

There is no review for this product at the moment, but you can be the first to add or you can read more in Testimonials Page about related products.
Package Example
Front View
Side View
Back View
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Shipping method Delivery time Price  
Delivery 14-21 days 14.95$ Tracking# available in 4 days
Delivery 9-14 days 30$ Tracking# available in 2 days
  • Shipping worldwide
  • Confidentiality and anonymity guarantee
  • Safe and secure
  • Discrete looking packages
  • Dispatch orders within 24 hours
  • 100% success delivery